Adimmune Company Description

Adimmune Corporation manufactures and sells human vaccines in Taiwan.

It offers AdimFlu-S, a quadrivalent influenza vaccine; tetanus toxoid alum precipitated product that is used for the prevention of tetanus after injury; Japanese encephalitis vaccines; Trivalent influenza vaccines; Quadrivalent influenza vaccine; Influenza A (H1N1) Virus Monovalent Vaccine; Tetanus Toxoid; and purified Tuberculin, as well as contract manufacturing services.

The company was formerly known as Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. and changed its name to Adimmune Corporation in 2001.

Adimmune Corporation was founded in 1965 and is headquartered in Taichung, Taiwan.

Adimmune Corporation

Country	Taiwan
Founded	1965
Industry	Biotechnology
Sector	Healthcare
Employees	564
CEO	Chi-Hsien Chan

Contact Details

Address: No. 3, Tanxing Road Taichung, 427003 Taiwan
Phone	886 4 2538 1220
Website	adimmune.com.tw

Stock Details

Ticker Symbol	4142
Exchange	Taiwan Exchange
Fiscal Year	January - December
Reporting Currency	TWD
ISIN Number	TW0004142005
SIC Code	2836

Key Executives

Name	Position
Chi-Hsien Chan	Chief Executive Officer and Chairman
Chung-Cheng Liu	President, GM and Director
Chin-Chuan Chang	Chief Operating Officer and Vice President of Research & Development
Fei Pan	Chief Legal Officer and General Counsel
Dr. Chun Cheng Chen M.B.A., M.D., M.Sc., Ph.D.	Chief Medical Officer
Yin-Teng Chang	Chief Financial Officer
Li-Ya Tang	Director of Administration Center
Chih-Hsiang Leng	Head of Research & Development Division
Chin-I Chiu	Vice President of Quality Assurance Department